Abstract
Aim: The benefit of chemotherapy as neoadjuvant or concurrent with radiotherapy in terms of overall survival has been demonstrated in locally advanced head and neck squamous cell cancer. We aimed to assess the efficacy and safety of concurrent capecitabine and cisplatin over concurrent cisplatin and 5-FU in locally advanced squamous cell oral cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurological Surgery Part B: Skull Base
Paper Title
Journal
Date
